NRP1 has been reported to be an oncogene by participating in the development and progression of cancers, such as lung adenocarcinoma (55), breast cancer (56), prostate cancer (57), and gastric cancer (58). This evidence concerns the gene NRP1 and lung adenocarcinoma.